Back to LLY
Candriam S.C.A. LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
6
Latest value
$465.9M
Q3 2026
Peak value
$481.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $351.1M |
| Q4 2025 | $480.4M |
| Q4 2025 | $479.6M |
| Q1 2026 | $383.8M |
| Q2 2026 | $481.7M |
| Q3 2026 | $465.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $465.9M | 401.2K | — | — |
| Q2 2026 | $481.7M | 402.0K | — | — |
| Q1 2026 | $383.8M | 417.3K | — | — |
| Q4 2025 | $479.6M | 446.3K | — | — |
| Q4 2025 | $480.4M | 447.0K | — | — |
| Q3 2025 | $351.1M | 460.1K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B